Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
DCFirst Claim
Patent Images
1. An oral dosage form in the form of a capsule which comprises:
- 1) pomalidomide at an amount of 0.1 to 3 weight percent of the total weight of the composition;
2) a binder or filler at an amount of 90 to 99 weight percent of total weight of the composition, wherein the binder or filler is a mixture of starch and mannitol; and
wherein the ratio of mannitol;
starch in the dosage form is from about 1;
1 to about 1;
1.5.
1 Assignment
Litigations
0 Petitions
Accused Products
Abstract
Pharmaceutical compositions and single unit dosage forms of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione, or a pharmaceutically acceptable stereoisomer, prodrug, salt, solvate, hydrate, or clathrate, are provided herein. Also provided are methods of treating, managing, or preventing various disorders, such as cancer or an inflammatory disease.
56 Citations
8 Claims
-
1. An oral dosage form in the form of a capsule which comprises:
- 1) pomalidomide at an amount of 0.1 to 3 weight percent of the total weight of the composition;
2) a binder or filler at an amount of 90 to 99 weight percent of total weight of the composition, wherein the binder or filler is a mixture of starch and mannitol; andwherein the ratio of mannitol;
starch in the dosage form is from about 1;
1 to about 1;
1.5. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
- 1) pomalidomide at an amount of 0.1 to 3 weight percent of the total weight of the composition;
Specification